Neoadjuvant Sunvozertinib in Stage II-IIIB Non-small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutation.

Clinical trial NCT07274761 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07274761
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Potentially Resectable EGFR Exon 20 Insertion Non-Small Cell Lung Cancer Non Small Cell Lung Cancer

Start date: 2024-10-17
Primary completion: 2030-05-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.